Login
Login     |     Register     |     Recover Username/Password

General Investing

Vet Care: An Attractive Refuge From Health Care

June 14, 2010

While reform continues to riddle the health care sector with uncertainty regarding the fiscal stability of Medicare and Medicaid, and the possibility of subsequent reimbursement rate reductions, the veterinary care space offers an attractive refuge to those investors seeking to benefit from the demographic trends and non-cyclical demand characteristics of human health care without the overriding risk.

“Certainly over the long term we are quite bullish on this space. We think it’s a very attractive investment alternative to the human health care companies, as veterinary medicine is not subject to many of the key issues or risks facing the human market,” said Ryan S. Daniels, a principal of William Blair & Company, LLC. “What I mean by that is veterinary health care is a cash-based business, so animal hospitals, like VCA Antech (WOOF), or laboratory diagnostic providers, like IDEXX Laboratories (IDXX), or distributors, like MWI Veterinary Supply (MWIV), don’t really have bad debt exposure. Compare that to a typical acute care hospital, with high-single- to low-double-digit bad debt.”

In addition, Daniels points out that vet care is immune to the third-party payer risk currently threatening human health care, and it is not subject to annual contract negotiations with managed care, malpractice risk or pending Medicaid uncertainty.

“We like the cash-based characteristics, people’s willingness to spend on their pets, that human-animal bond. It just has a lot of very attractive long-term features,” Daniels said. “We expect [veterinary care] to grow again this year. It was very modest growth last year, but long term I think it’s going to be similar to the past, which is roughly two times GDP growth in the U.S.”


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now